Tampa pharma firm elects new chair
April 15, 2019 - HedgePath Pharmaceuticals elected W. Mark Watson as chairman of the board, effective April 15. Watson, who is been on the HedgePath (OTC: HPPI) board since 2014, is a CPA who also serves on the board of Sykes Enterprises (Nasdaq: SYKE). E. Brendan Magrab, who has been HedgePath chair, is stepping down from that position in order to fulfill his duties as CEO of Epalex Corp., a news release said.